Clinical Trials Logo

Nausea Post Chemotherapy clinical trials

View clinical trials related to Nausea Post Chemotherapy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04669132 Completed - Clinical trials for Nausea Post Chemotherapy

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

OLNEPA
Start date: December 17, 2020
Phase: Phase 2
Study type: Interventional

This is a longitudinal, one arm, prospective phase II study, designed to evaluate the efficacy of Olanzapine Netupitant and Palonosetron in the controll of nausea and vomiting induced by highly emetogenic chemotherapy.

NCT ID: NCT03572829 Completed - Vomiting Clinical Trials

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Start date: March 1, 2018
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of aprepitant combined with ondansetron and dexamethasone to prevent nausea and vomiting induced by Intensity-modulated Radiotherapy (IMRT) cisplatin-chemotherapy regimen in locally advanced squamous cell carcinoma of head and neck

NCT ID: NCT01504711 Completed - Clinical trials for Gastrointestinal Cancer

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Start date: June 2012
Phase: N/A
Study type: Interventional

This clinical trial studies fosaprepitant dimeglumine in preventing nausea and vomiting in patients with gastrointestinal cancer receiving combination chemotherapy. Antiemetic drugs, such as fosaprepitant dimeglumine, may help lessen or prevent nausea and vomiting in patients treated with chemotherapy.